A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen

• Main Authors: Yuki Okada (Author), Daisuke Hitaka (Author), Takahiro Kido (Author), Yu Kanai (Author), Kumi Konishi (Author), Kosuke Doki (Author), Nobuko Katayama (Author), Masato Homma (Author), Yayoi Miyazono (Author), Hidetoshi Takada (Author)
• Format: Book
• Published: Hindawi Limited, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Tamoxifen, an estrogen receptor antagonist, is contraindicated in pregnant women due to its teratogenic activity. In the present study, we report the case of an infant whose mother received tamoxifen for breast cancer while unaware of the pregnancy. The infant, born at 29 weeks and 6 days of gestati...